Guardian Pharmacy Services (NYSE:GRDN) Price Target Raised to $38.00

Guardian Pharmacy Services (NYSE:GRDN) had its target price boosted by Oppenheimer from $35.00 to $38.00 in a report published on Thursday morning,Benzinga reports. The brokerage currently has an outperform rating on the stock.

GRDN has been the topic of a number of other research reports. Truist Financial boosted their price target on Guardian Pharmacy Services from $34.00 to $38.00 and gave the stock a “buy” rating in a research report on Thursday. UBS Group reaffirmed a “buy” rating on shares of Guardian Pharmacy Services in a research report on Thursday. Weiss Ratings reiterated a “hold (c+)” rating on shares of Guardian Pharmacy Services in a research note on Monday, December 29th. Stephens boosted their target price on Guardian Pharmacy Services from $35.00 to $36.00 and gave the stock an “overweight” rating in a report on Wednesday, January 14th. Finally, Wall Street Zen upgraded Guardian Pharmacy Services from a “buy” rating to a “strong-buy” rating in a research note on Monday, November 17th. Five equities research analysts have rated the stock with a Buy rating and one has given a Hold rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $38.00.

Guardian Pharmacy Services Price Performance

Shares of GRDN opened at $32.53 on Thursday. The firm has a 50-day moving average of $31.93 and a 200-day moving average of $29.41. Guardian Pharmacy Services has a one year low of $19.17 and a one year high of $37.43. The company has a market cap of $2.06 billion, a PE ratio of 42.24 and a beta of 0.86.

Guardian Pharmacy Services (NYSE:GRDN) last released its quarterly earnings data on Wednesday, March 11th. The company reported $0.37 earnings per share for the quarter, topping the consensus estimate of $0.27 by $0.10. The company had revenue of $397.62 million for the quarter, compared to analyst estimates of $390.04 million. Guardian Pharmacy Services had a net margin of 3.40% and a return on equity of 33.34%. The firm’s quarterly revenue was up 17.4% compared to the same quarter last year. Analysts expect that Guardian Pharmacy Services will post 0.87 earnings per share for the current year.

Institutional Investors Weigh In On Guardian Pharmacy Services

Hedge funds have recently bought and sold shares of the stock. Ameritas Investment Partners Inc. boosted its holdings in shares of Guardian Pharmacy Services by 26.5% during the third quarter. Ameritas Investment Partners Inc. now owns 1,647 shares of the company’s stock worth $43,000 after acquiring an additional 345 shares during the period. California State Teachers Retirement System increased its stake in shares of Guardian Pharmacy Services by 3.4% during the fourth quarter. California State Teachers Retirement System now owns 17,983 shares of the company’s stock worth $541,000 after purchasing an additional 593 shares during the period. Envestnet Asset Management Inc. increased its stake in shares of Guardian Pharmacy Services by 7.1% during the second quarter. Envestnet Asset Management Inc. now owns 12,126 shares of the company’s stock worth $258,000 after purchasing an additional 805 shares during the period. Police & Firemen s Retirement System of New Jersey lifted its holdings in Guardian Pharmacy Services by 20.4% during the 4th quarter. Police & Firemen s Retirement System of New Jersey now owns 6,070 shares of the company’s stock worth $183,000 after purchasing an additional 1,028 shares during the last quarter. Finally, State of Alaska Department of Revenue acquired a new stake in Guardian Pharmacy Services during the 3rd quarter worth approximately $30,000.

Guardian Pharmacy Services Company Profile

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company’s Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs.